Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP14 | P50281 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL676909 | 0.84 | KMT2A (0.58) | KMT2AMEN1ALDH1A1MAPTHSD17B10 | |
| SCHEMBL8942876 | 0.78 | TDP1 (0.44) | KMT2AMEN1ALDH1A1MAPTHSD17B10 | |
| SCHEMBL486023 | 0.78 | ELANE (0.62) | KMT2AMEN1MAPTHTTELANE | |
| SCHEMBL5731400 | 0.78 | ALDH1A1 (0.44) | KMT2AMEN1ALDH1A1MAPTLMNA | |
| SCHEMBL697317 | 0.77 | CA1 (0.56) | KMT2AMEN1ALDH1A1HTTLMNA | |
| SCHEMBL27496383 | 0.77 | HPGD (0.57) | KMT2AMEN1ALDH1A1MAPTHSD17B10 | |
| SCHEMBL6936328 | 0.77 | MMP2 (0.55) | KMT2AMEN1ALDH1A1MAPTHSD17B10 | |
| SCHEMBL8779173 | 0.77 | KMT2A (0.52) | KMT2AMEN1ALDH1A1MAPTHSD17B10 | |
| SCHEMBL29250 | 0.77 | HPGD (0.57) | KMT2AMEN1ALDH1A1MAPTHSD17B10 | |
| SCHEMBL128884 | 0.77 | LMNA (0.58) | KMT2AMEN1ALDH1A1MAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020196666-A1 | POLYOL BLEND LIQUID FOR PRODUCING HALOALKENE POLYURETHANE FOAM | 東ソー株式会社 | 2020-10-01 | — | — | WO | disclosed |
| EP-2354123-B1 | NOVEL SULFONIUM BORATE COMPLEX | DEXERIALS CORP (JP) | 2015-02-25 | — | — | EP | disclosed |
| US-8877878-B2 | Epoxy resin composition with sulfonium borate complex | DEXERIALS CORPORATION (JP) | 2014-11-04 | — | — | US | disclosed |
| US-8710662-B2 | Light-reflective anisotropic conductive paste and light-emitting device | Sony Corporation & Information Device Corporation (JP) | 2014-04-29 | — | — | US | disclosed |
| EP-2581955-A1 | LIGHT-REFLECTIVE ANISOTROPIC ELECTRICALLY CONDUCTIVE PASTE, AND LIGHT-EMITTING DEVICE | Sony Chemical & Information Device Corporation (JP) | 2013-04-17 | — | — | EP | disclosed |
| US-20120248495-A1 | LIGHT-REFLECTIVE ANISOTROPIC CONDUCTIVE PASTE AND LIGHT-EMITTING DEVICE | SONY CHEMICAL & INFORMATION DEVICE CORPORATION (JP) | 2012-10-04 | — | — | US | disclosed |
| US-20110192639-A1 | NOVEL SULFONIUM BORATE COMPLEX | SONY CHEMICAL & INFORMATION DEVICE CORPORATION (JP) | 2011-08-11 | — | — | US | disclosed |
| EP-2354123-A1 | NOVEL SULFONIUM BORATE COMPLEX | Sony Chemical & Information Device Corporation (JP) | 2011-08-10 | — | — | EP | disclosed |
| US-7820355-B2 | Radiation sensitive resin composition | ZEON CORPORATION (JP) | 2010-10-26 | — | — | US | disclosed |
| EP-1043021-B1 | PURINE DERIVATIVES FOR THE TREATMENT OF ALLERGIC DISEASES AND SYSTEMIC LUPUS ERYTHEMATOSUS | DAINIPPON SUMITOMO PHARMA CO (JP) | 2006-05-03 | — | — | EP | disclosed |
| US-6376501-B1 | INHIBITING OR REGULATING IMMUNE RESPONSE USING PURINE-DERIVED COMPOUND; NON-STEROIDAL COMPOUND | JAPAN ENERGY CORPORATION (JP) | 2002-04-23 | — | — | US | disclosed |
| US-6310070-B1 | FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS | JAPAN ENERGY CORPORATION (JP) | 2001-10-30 | — | — | US | disclosed |
| EP-1043021-A1 | TYPE 2 HELPER T CELL-SELECTIVE IMMUNE RESPONSE SUPPRESSORS | Japan Energy Corporation (JP) | 2000-10-11 | — | — | EP | disclosed |
| EP-0999211-A1 | NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF | JAPAN ENERGY CORPORATION (JP) | 2000-05-10 | — | — | EP | disclosed |
| US-6028076-A | FOR INDUCING .ALPHA.-INTERFERON IN A PATIENT HAVING HEPATITIS B OR C, BY ADMINISTERING PURINE DERIVATIVE | JAPAN ENERGY CORPORATION (JP) | 2000-02-22 | — | — | US | disclosed |
| EP-0882727-A1 | NOVEL PURINE DERIVATIVES | JAPAN ENERGY CORPORATION (JP) | 1998-12-09 | — | — | EP | disclosed |
| EP-0324431-B1 | NEW INDOLYLPIPERIDINE COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-03-25 | — | — | EP | disclosed |
| US-5017703-A | Antiallergens, antiinflammatory | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1991-05-21 | — | — | US | disclosed |
| US-4935432-A | ANTIALLERGENS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-06-19 | — | — | US | disclosed |
| EP-0324431-A1 | New indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110192639-A1 | NOVEL SULFONIUM BORATE COMPLEX | EBPL, ITGB1, ITGA1 | KMT2A 2179/4885MEN1 2130/4885ALDH1A1 1984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.